GLP-1 drugs and surgery: what anesthesiologists actually worry about

What did @dr.digs_mindfullmugcake actually say?

The video is seven words: "Just answer the question, okay? Please don't play with me right now." That's it. No medical claim, no protocol explanation, no drug recommendation. The creator appears to be venting about a pre-surgical patient who isn't giving clear answers before anesthesia begins.

Given the GLP-1 category tag, the most plausible reading is that this plays into a well-known clinical headache: patients on semaglutide, tirzepatide, or other GLP-1 receptor agonists who don't disclose their medication use before surgery. Or possibly patients who can't confirm whether they followed the required pre-op fasting and medication hold instructions. Either scenario is genuinely consequential in an operating room setting, but the video doesn't say any of that out loud.

What you're watching is a mood, not a medical lecture. That matters for how we evaluate it.

Does the science back this up?

The frustration implied here is well-supported by real clinical literature, even if the creator never actually states a claim. GLP-1 agonists slow gastric emptying significantly, and that creates a measurable aspiration risk under general anesthesia even after standard fasting windows.

A 2023 letter in Anesthesiology from Joshi et al. flagged that standard NPO (nil per os) guidelines may be insufficient for patients on GLP-1 medications because gastric contents can persist longer than expected. The American Society of Anesthesiologists followed up with guidance in 2023 recommending that anesthesiologists consider holding GLP-1 drugs before elective procedures, with the exact hold duration still debated. A 2024 review in the British Journal of Anaesthesia by Sherwin et al. reinforced that delayed gastric emptying in GLP-1 users is measurable on imaging even after an overnight fast. Patients who don't disclose GLP-1 use, or who didn't hold the drug, genuinely put surgical teams in a difficult position. The science does back the implied concern here.

What did they get wrong (or right)?

There is nothing factually wrong in this video because there are no factual statements. What the creator got right, implicitly, is that pre-surgical communication about GLP-1 use is a real clinical issue that deserves more attention.

What's missing is any actual information for patients watching. If 126,000 people see a surgeon looking exasperated before a surgery, the useful follow-up question is: what should a GLP-1 patient actually tell their surgical team? The video doesn't answer that. It generates relatability for other clinicians and anxiety for patients without giving anyone a usable takeaway.

The GLP-1 category tag does the heavy lifting here in terms of context. Without it, this is just a frustrated doctor clip. With it, the implied message is that patients on these drugs need to be upfront about their use before surgery. That's a fair message, just never actually delivered.

What should you actually know?

If you are taking a GLP-1 medication like semaglutide or tirzepatide and you have surgery scheduled, disclosure is not optional. The ASA's 2023 guidance recommends holding weekly GLP-1 injections for one week before elective procedures, and daily formulations for the day of surgery, though your prescribing physician should make that call for your specific case.

Aspiration during anesthesia, where stomach contents enter the airway, is rare but serious. GLP-1 drugs slow the movement of food out of the stomach, which means the standard overnight fast may not be enough to empty your stomach before an operation. Anesthesiologists need to know this before they put you under.

• Tell your surgeon and anesthesiologist about every medication you take, including GLP-1 drugs, at your pre-op appointment.
• Do not assume that because GLP-1 drugs are prescribed for weight management they are irrelevant to your surgical team.
• If you are unsure whether to hold your dose before surgery, contact your prescribing provider before the procedure, not the morning of.
• Gastric ultrasound is increasingly used to assess residual stomach contents in GLP-1 users before anesthesia, per the Sherwin et al. 2024 review in the British Journal of Anaesthesia.